The British company European Metal Recycling (EMR) commissioned its Hamburg battery recycling plant last week. Following extensive modifications at the site in the city's Billbrook quarter, the ...

Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...

East Midlands Railway (EMR) has confirmed that it will begin handing back its fleet of 222s back to Eversholt Group with three sets due to move between September and December. However, as it begins ...

Ticketless train travel that works by tracking passengers' locations is being trialled in the East Midlands. The location-based technology will be tested by East Midlands Railway (EMR) from Monday, by ...

A business.com editor verified this analysis to ensure it meets our standards for accuracy, expertise and integrity. AdvancedMD offers the features, flexibility and scalability medical practices need ...

The electromechanical reshaping technique successfully flattened this rabbit cornea, shown in a cross section, from its original shape (white line) to a corrected one (yellow line). WASHINGTON, Aug.

Praxis has just extended its Doon crank family with a gravel-specific model — the Doon GR — combining everything we loved about the award-winning road version with tweaks for off-road adventures. The ...

Emerson exited the first half of FY25 with flat top line growth as softness in discrete automation offset strength in software and process businesses. Near-term outlook remains mixed, but improving ...

Dryden Brown is a slight man of 29, with a scruffy, reddish beard and a wry, serious demeanor. On the April afternoon we met at the Beverly Hills Hotel, his dark suit seemed out of place in the sunlit ...

We recently published a list of 12 Best Automation Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Emerson Electric Co. (NYSE:EMR) stands against other ...

BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...